NCT07110246
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07110246
Title Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas (PNOC037)
Acronym PNOC037
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of California, San Francisco
Indications
Therapies
Age Groups: adult | child
Covered Countries USA